| Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia J Styczynski, P Reusser, H Einsele, R De la Camara, C Cordonnier, ... Bone marrow transplantation 43 (10), 757-770, 2009 | 453 | 2009 |
| Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on … P Ljungman, R de la Camara, C Robin, R Crocchiolo, H Einsele, JA Hill, ... The Lancet infectious diseases 19 (8), e260-e272, 2019 | 421 | 2019 |
| Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT P Ljungman, R De La Camara, C Cordonnier, H Einsele, D Engelhard, ... Bone marrow transplantation 42 (4), 227-240, 2008 | 369 | 2008 |
| Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years JR Passweg, H Baldomero, C Chabannon, GW Basak, R de La Cámara, ... Bone marrow transplantation 56 (7), 1651-1664, 2021 | 368 | 2021 |
| Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth … J Styczynski, W van der Velden, CP Fox, D Engelhard, R de la Camara, ... Haematologica 101 (7), 803, 2016 | 358 | 2016 |
| Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow … P Ljungman, KN Ward, BNA Crooks, A Parker, R Martino, PJ Shaw, ... Bone marrow transplantation 28 (5), 479-484, 2001 | 344 | 2001 |
| Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT P Ljungman, D Engelhard, R De La Camara, H Einsele, A Locasciulli, ... Bone Marrow Transplantation 35 (8), 737-746, 2005 | 292 | 2005 |
| Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors J Styczyński, G Tridello, L Koster, S Iacobelli, A van Biezen, ... Bone marrow transplantation 55 (1), 126-136, 2020 | 288 | 2020 |
| Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients R Martino, M Subirá, M Rovira, C Solano, L Vázquez, GF Sanz, ... British journal of haematology 116 (2), 475-482, 2002 | 275 | 2002 |
| Bloodstream infections among transplant recipients: Results of a nationwide surveillance in spain1 A Moreno, C Cervera, J Gavaldá, M Rovira, R De La Cámara, I Jarque, ... American Journal of Transplantation 7 (11), 2579-2586, 2007 | 266 | 2007 |
| Response to rituximab-based therapy and risk factor analysis in Epstein Barr virus–related lymphoproliferative disorder after hematopoietic stem cell transplant in children and … J Styczynski, L Gil, G Tridello, P Ljungman, JP Donnelly, ... Clinical infectious diseases 57 (6), 794-802, 2013 | 263 | 2013 |
| Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022 JA Snowden, I Sánchez-Ortega, S Corbacioglu, GW Basak, C Chabannon, ... Bone marrow transplantation 57 (8), 1217-1239, 2022 | 260 | 2022 |
| Antimicrobial resistance in Gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the Infectious … D Averbuch, G Tridello, J Hoek, M Mikulska, H Akan, ... Clinical Infectious Diseases 65 (11), 1819-1828, 2017 | 255 | 2017 |
| Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation P Ljungman, R Brand, J Hoek, R de la Camara, C Cordonnier, H Einsele, ... Clinical Infectious Diseases 59 (4), 473-481, 2014 | 255 | 2014 |
| The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients … P Ljungman, M Mikulska, R de La Camara, GW Basak, C Chabannon, ... Bone marrow transplantation 55 (11), 2071-2076, 2020 | 244 | 2020 |
| IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study JM Galván-Román, SC Rodríguez-García, E Roy-Vallejo, ... Journal of Allergy and Clinical Immunology 147 (1), 72-80. e8, 2021 | 235 | 2021 |
| Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants P Ljungman, R De la Camara, N Milpied, L Volin, CA Russell, A Crisp, ... Blood, The Journal of the American Society of Hematology 99 (8), 3050-3056, 2002 | 229 | 2002 |
| Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone … R Parody, R Martino, M Rovira, L Vazquez, MJ Vázquez, R de la Cámara, ... Biology of blood and marrow transplantation 12 (7), 734-748, 2006 | 226 | 2006 |
| COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey P Ljungman, R de la Camara, M Mikulska, G Tridello, B Aguado, ... Leukemia 35 (10), 2885-2894, 2021 | 216 | 2021 |
| Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study C Cordonnier, M Rovira, J Maertens, E Olavarria, C Faucher, K Bilger, ... Haematologica 95 (10), 1762, 2010 | 182 | 2010 |
Jan StyczynskiCollegium Medicum Bydgoszcz, Nicolaus Copernicus University TorunVerified email at cm.umk.pl
